Two years after the first emergence of SARS-CoV-2, various new waves of COVID-19 have swept across Europe. Our researchers have been searching for ways to lower the COVID-19 burden on healthcare systems. Prof. Wim Vanden Berghe’s lab (PPES) has been testing whether the medicinal plant extract Echinacea purpurea can be used to treat Coronavirus infections.
During her PhD research in Biomedical Sciences, Emilie Logie aimed to find new treatment options to overcome therapy resistance in the blood cancer multiple myeloma. Together with Professor Wim Vanden Berghe, her supervisor at the Proteinchemistry, Proteomics and Epigenetic Signalling (PPES) lab, Emilie used and combined different molecular techniques to identify new ways for treating therapy-resistant multiple myeloma cancers.